DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > Collagenex Pharmaceuticals Aktie > Nachrichten zu Collagenex Pharmaceuticals

Collagenex Pharmaceuticals Aktie [WKN: 901491 / ISIN: US19419B1008]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
Börsenplätze Kursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Collagenex Pharmaceuticals Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Collagenex Pharmaceuticals Inc.

19.03.08CollaGenex Pharmaceuticals Announces Expiration of the Hart-Scott-Rodino Waiting Period for Merger with Galderma Pharma S.A.
12.03.08CollaGenex Pharmaceuticals Reports Financial Results for the Fourth Quarter and Full Year 2007
05.03.08CollaGenex Pharmaceuticals to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call on March 12th
26.02.08CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
14.02.08CollaGenex Pharmaceuticals to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference on February 20th
23.01.08CollaGenex Pharmaceuticals to Present at the 2008 Wachovia Healthcare Conference on January 30th
17.01.08CollaGenex Pharmaceuticals Announces Results of Phase 4 Clinical Study Showing Oracea Equally Effective as 100 mg Doxycycline in Treatment of Rosacea
14.01.08CollaGenex Pharmaceuticals Initiates Phase 2 Dose-Finding Study of Becocalcidiol for the Treatment of Psoriasis
05.12.07CollaGenex Pharmaceuticals to Present at the RBC Capital Markets' Healthcare Conference on December 12th
27.11.07CollaGenex Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference on December 4th
20.11.07CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets 4th Annual Healthcare Conference on November 27th
06.11.07CollaGenex Pharmaceuticals Reports Financial Results for the Third Quarter of 2007
24.10.07CollaGenex Pharmaceuticals to Host Third Quarter 2007 Financial Results Conference Call on November 6th
26.09.07CollaGenex Pharmaceuticals Announces Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Rosacea
20.09.07CollaGenex Pharmaceuticals to Present at the UBS 2007 Global Life Sciences Conference on September 27th
30.08.07CollaGenex Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2007 on September 6th
23.08.07CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema
07.08.07CollaGenex Pharmaceuticals Reports Financial Results for the Second Quarter and First Half of 2007
26.07.07CollaGenex Pharmaceuticals to Host Second Quarter and First Half of 2007 Financial Results Conference Call on August 7th
21.06.07CollaGenex Pharmaceuticals to Present at Jefferies Life Sciences Conference on June 28th
20.06.07CollaGenex Pharmaceuticals to Present at the 17th Annual Wachovia Nantucket Equity Conference on June 27th
21.03.06CollaGenex Pharmaceuticals Reports Notice of Allowance for European Patent Covering Oracea(TM)
27.02.06CollaGenex Pharmaceuticals' Announces Filing of Marketing Authorization Application for ORACEA(TM) with the Medicines & Healthcare Products Regulatory Agency in the United Kingdom
16.05.05CollaGenex Announces Restructuring Following FDA Approval of Generic F
05.05.05CollaGenex Pharmaceuticals Reports Financial Results for the First Qua
28.04.05CollaGenex Pharmaceuticals to Hold First Quarter 2005 Earnings Confere
15.04.05CollaGenex Pharmaceuticals Reports Positive Outcome of Phase 2 Clinica
17.03.05Magistrate Recommends Denial of CollaGenex Pharmaceuticals Motion for
10.03.05CollaGenex Pharmaceuticals Reports Financial Results for the Fourth Qu
07.03.05CollaGenex Pharmaceuticals to Present at the SG Cowen 25th Annual Heal
07.03.05U.S. Patent and Trademark Office Notifies CollaGenex That It Will Conf
01.03.05CollaGenex Pharmaceuticals to Hold Fourth Quarter and Year End 2004 Ea
14.02.05CollaGenex Pharmaceuticals to Present at the Roth Capital Partners 17t
25.01.05Court Temporarily Prevents Sales of Generic Versions of Periostat Pend
20.01.05CollaGenex Pharmaceuticals Seeks Immediate Injunctive Relief to Enforc

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon